ArticleBreast (Edinburgh, Scotland)2020

Clinical utility of tumour marker velocity of cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in breast cancer surveillance.

J X Hing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.